(Q35047679)

6 August 2017

0 references

0 references

An update on a systematic review of the use of geriatric assessment for older adults in oncology (English)

1 reference

6 August 2017

1 reference

E Springall

7

0 references

Eshetu G. Atenafu

object named as

E G Atenafu

6

0 references

Shabbir Alibhai

8

object named as

S M H Alibhai

1 reference

6 August 2017

M T E Puts

1

1 reference

6 August 2017

B Santos

2

1 reference

6 August 2017

J Hardt

3

1 reference

6 August 2017

J Monette

4

1 reference

6 August 2017

V Girre

5

1 reference

6 August 2017

language of work or name

1 reference

19 November 2013

1 reference

6 August 2017

1 reference

6 August 2017

volume

25

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

307-315

1 reference

Future of cancer incidence in the United States: burdens upon an aging, changing nation

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Beyond diagnosis: rising to the multimorbidity challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Multimorbidity: an issue of growing importance for oncologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Designing health care for the most common chronic condition--multimorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

EORTC elderly task force position paper: approach to the older cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Use of geriatric assessment for older adults in the oncology setting: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Screening older cancer patients: first evaluation of the G-8 geriatric screening tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

The value of a comprehensive geriatric assessment for patient care in acutely hospitalized older patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (t

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Screening older cancer patients for a Comprehensive Geriatric Assessment: A comparison of three instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Examining five- and ten-year survival in older women with breast cancer using cancer-specific geriatric assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Frailty: an outcome predictor for elderly gynecologic oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Frailty in older adults: evidence for a phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Quality-of-life in elderly patients with cancer: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Are older French patients as willing as older American patients to undertake chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Comprehensive geriatric assessment for older patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

Impact and Feasibility of a Comprehensive Geriatric Assessment in the Oncology Setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT386

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT386

1 reference

6 August 2017

1 reference